Q1 Earnings Estimate for NovoCure Issued By Leerink Partnrs
NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for NovoCure in a note issued to investors on Thursday, February 27th. Leerink Partnrs analyst J. Chang anticipates that the medical equipment provider will post earnings per share of ($0.44) for the quarter. […]
NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for NovoCure in a note issued to investors on Thursday, February 27th. Leerink Partnrs analyst J. Chang anticipates that the medical equipment provider will post earnings per share of ($0.44) for the quarter. […]
